• Author: Timothy S. Anderson
Clear all

Early outcomes of lecanemab for Alzheimer’s disease in the Veterans Health Administration

Abstract: Background/Objectives: While lecanemab (Leqembi) and several amyloid targeting therapies were approved for Alzheimer’s disease, questions remain on real-world …

VA-purchased community care and risk of potentially unsafe concurrent medication use among Veterans receiving opioids: A regression discontinuity analysis

Abstract: Objective: To examine whether eligibility for Veterans Health Administration (VA) community care, which expanded Veterans' access to VA-funded care outside VA, increased …

VA‐purchased community care and risk of potentially unsafe concurrent medication use among Veterans receiving opioids: A regression discontinuity analysis

Abstract: Objective: To examine whether eligibility for Veterans Health Administration (VA) community care, which expanded Veterans' access to VA-funded care outside VA, increased …